Functional imaging in neuroendocrine tumors: assessment of molecular heterogeneity using [68Ga]Ga-DOTA-TOC and [18F]FDG PET/CT.

OBJECTIVE: The aim of the study was evaluate the diagnostic performance of [68Ga]Ga-DOTA-TOC and [18F]FDG PET/CT in patients with histologically proven neuroendocrine tumors (NETs), as well as the correlation of the visualized findings with the tumor grade. MATERIAL AND METHODS: We included 50 patients with NETs who underwent both [68Ga]Ga-DOTA-TOC and [18F]FDG PET/TC. The pooled sensitivity of both scans was compared, as well as [68Ga]Ga-DOTA-TOC and [18F]FDG for each tumor grade (grade 1/G1, grade 2/G2 and grade 3/G3). Also, the sensitivity of [68Ga]Ga-DOTA-TOC and [18F]FDG as a function of the continuous variable Ki-67 was investigated. Finally, the number of lesions detected by both PET radiopharmaceuticals for each tumor grade was compared. RESULTS: The pooled sensitivity of both PET/CT (96%) was higher than [68Ga]Ga-DOTA-TOC (84%) and [18F]FDG (44%) separately, with statistically significant differences. The sensitivity of [68Ga]Ga-DOTA-TOC was higher than [18F]FDG in both G1 (p = 0.004) and G2 (p < 0.001). In G3 the performance of both scans detected disease in 100% of this subgroup. The sensitivity of [68Ga]Ga-DOTA-TOC and [18F]FDG PET/CT correlated significantly with the Ki-67 proliferative index. In G2 patients the number of lesions detected with [68Ga]Ga-DOTA-TOC was higher than [18F]FDG. CONCLUSIONS: The performance of both PET/CT, particularly in G2 and G3, demonstrates the molecular heterogeneity of metastatic NETs and contributes to the selection of a more appropriate treatment, particularly in those high-grade patients who may benefit from radionuclide therapy (PRRT).

Nursing interventions in palliative care in the intensive care unit: A systematic review.

CONTEXT: Patients in palliative care are found in different places where care is provided, including the intensive care environment with important role of the nursing staff. OBJECTIVE: The aim of this systematic review was to answer the following question: which nursing interventions are aimed to the palliative care patients who are in the intensive care unit (ICU). DATA SOURCES: US National Library of Medicine (PUBMED), Virtual Health Library (BVS), SciELO, The Cochrane Library (Cochrane) and Lilacs databases were used. DATA EXTRACTION: After applying inclusion and exclusion criteria in accordance with the PRISMA method, a total of 36 entries published between 2010 and 2020 were used. DATA ANALYSIS: The records extracted were analyzed from a qualitative approach, so no statistical analysis was carried out. RESULTS: The findings demonstrated that the interventions that focus on promoting the patient's autonomy and respect their needs on ICU involves effective communication, promoting shared decision with patient and family, individualize care for each patient including the family on the daily care and decisions, maintaining basic nursing care as hygiene and comfort and encouraging self-care, as well as the involvement of nursing palliative care specialists the care is important. Other interventions included promoting a continuing education program for the nursing staff and other professionals involved in caring for patients in palliative care at ICU. CONCLUSION: This review highlighted the need for specific nursing interventions aimed at palliative care patients at ICU to promote patient autonomy and the focus on patient needs, always sharing decisions with the patient and family. However, it showed that there is a need for the continuous training of the nursing staff because factors such as the nurses' lack of technical-scientific knowledge and, concomitantly, the absence of a standardized and specific intervention model linked to a bureaucratic system, make it difficult to carry out a specialized care for this type of patient.

Nursing interventions in palliative care in the intensive care unit: A systematic review / Intervenciones de enfermería en cuidados paliativos en la unidad de cuidados

Context: Patients in palliative care are found in different places where care is provided, including the intensive care environment with important role of the nursing staff. Objective: The aim of this systematic review was to answer the following question: which nursing interventions are aimed to the palliative care patients who are in the intensive care unit (ICU). Data sources: US National Library of Medicine (PUBMED), Virtual Health Library (BVS), SciELO, The Cochrane Library (Cochrane) and Lilacs databases were used. Data extraction: After applying inclusion and exclusion criteria in accordance with the PRISMA method, a total of 36 entries published between 2010 and 2020 were used. Data analysis: The records extracted were analyzed from a qualitative approach, so no statistical analysis was carried out. Results: The findings demonstrated that the interventions that focus on promoting the patient's autonomy and respect their needs on ICU involves effective communication, promoting shared decision with patient and family, individualize care for each patient including the family on the daily care and decisions, maintaining basic nursing care as hygiene and comfort and encouraging self-care, as well as the involvement of nursing palliative care specialists the care is important. Other interventions included promoting a continuing education program for the nursing staff and other professionals involved in caring for patients in palliative care at ICU...(AU)

Contexto: Los pacientes en cuidados paliativos se encuentran en varios lugares, incluso en cuidados intensivos, y las enfermeras tienen un papel importante en el cuidado de este tipo de pacientes. Objetivo: Esta revisión sistemática buscó responder a la siguiente pregunta: ¿Cuáles son las intervenciones de enfermería dirigidas a los pacientes en cuidados paliativos en la unidad de cuidados intensivos (UCI)?. Fuentes de datos: Biblioteca Nacional de Medicina de EE. UU. (PUBMED), Biblioteca Virtual de Salud (BVS), SciELO, The Cochrane Library y Lilacs. Extracción de datos: Aplicación de los criterios de inclusión y exclusión según el método PRISMA, totalizando 36 estudios publicados entre 2010 y 2020. Análisis de datos: Los datos extraídos se analizaron con un enfoque cualitativo, por lo que no se realizó ningún análisis estadístico. Resultados: Las intervenciones que promueven la autonomía del paciente y respetan sus necesidades en la UCI involucran: comunicación efectiva, decisión compartida de individualizar el cuidado e incluir a la familia en el cuidado. Se debe mantener la higiene, el confort y la promoción del autocuidado, involucrando equipos de especialistas en cuidados paliativos, impulsando programas de educación continua para enfermeras de cuidados intensivos y otros profesionales implicados. Conclusión: Son necesarias intervenciones enfermeras dirigidas a pacientes con cuidados paliativos en la UC para promover la autonomía y satisfacer las necesidades del paciente, compartiendo siempre las decisiones con el paciente y su familia, y asimismo es necesaria la formación continua de las enfermeras en factores como el desconocimiento técnico-científico de este colectivo y, concomitantemente, la ausencia de un modelo estandarizado de intervención vinculado a un sistema burocrático. Todo ello dificulta la atención especializada a este tipo de pacientes.(AU)

Papel de los factores inflamatorios sistémicos en los tumores neuroendocrinos gastroenteropancreáticos (TNE-GEP) tratados con péptidos marcados con radionúclidos (PRRT): de la biología a la teragnosis / Role of systemic inflammatory factors in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with peptide receptor radionuclide therapy (PRRT): From biology to theragnosis

Objetivo Los índices inflamatorios sistémicos se han validado como indicadores de inflamación sistémica como marcadores predictivos de mal pronóstico para diversas enfermedades oncológicas. Sin embargo, se desconoce el impacto pronóstico de los marcadores de inflamación sistémica en pacientes con tumores neuroendocrinos gastroenteropancreáticos (TNE-GEP) tratados con péptidos marcados con radionúclidos (PRRT). Métodos Realizamos un estudio observacional, retrospectivo, multicéntrico de 40 pacientes con TNEs-GEP y TNE de origen desconocido tratados con PRRT entre el 2016 y el 2020. Los marcadores inflamatorios sistémicos se calcularon de la siguiente manera: relación neutrófilos a linfocitos (NLR)=recuento de neutrófilos/recuento de linfocitos, relación de monocitos a linfocitos (MLR)=recuento de monocitos/recuento de linfocitos, relación de plaquetas a linfocitos (PLR)=recuento de plaquetas/recuento de linfocitos, relación de albúmina a linfocitos (ALR)=niveles de albúmina/recuento de linfocitos y relación derivada de neutrófilos a linfocitos (dNLR)=recuento de neutrófilos/(recuento de leucocitos – recuento de neutrófilos). Se utilizaron datos analíticos basales pretratamiento y después de la segunda dosis para el cálculo de los distintos índices. Resultados La mediana de edad fue de 63 años (rango 41-85), el 55% eran hombres. Los valores de corte de referencia para NLR fueron 2,61, para MLR 0,31, para PLR 110,14, para ALR 2,39 y para dNLR 1,71. Los valores de corte después de la segunda dosis fueron, para NLR 2,3, para MLR 0,3, para PLR 131,61, ALR 4,16 y dNLR 1,48. La mediana de la sobrevivencia libre de progresión (SLP) fue de 21,7 meses (IC del 95%: 10,7-32,8 m) y la supervivencia global (SG) fue de 32,1 meses (IC del 95%: 19,6-44,7 m), la SLP fue más corta en pacientes con NLR elevado (p=0,001), ALR (0,03) y dNLR (p=0,001) en el análisis basal. La tasa de control de enfermedad (DCR) fue del 81% y la tasa de respuesta objetiva (ORR) del 18% (AU)

Aim Systemic inflammatory factors have been validated as indicators of ongoing systemic inflammation that could be predictive markers of poor prognosis for oncological outcomes. However, the prognostic impact of systemic inflammation markers is unknown in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with peptide receptor radionuclide therapy (PRRT). Methods We conducted an observational, retrospective, multicentric study of 40 patients with GEP or unknown origin NETs treated with PRRT between 2016 and 2020. The systemic inflammatory markers were calculated as follows: neutrophil to lymphocyte ratio (NLR)=neutrophil count/lymphocyte count, monocyte to lymphocyte ratio (MLR)=monocyte count/lymphocyte count, platelet to lymphocyte ratio (PLR)=platelet count/lymphocyte count, albumin to lymphocyte ratio (ALR)=albumin levels/lymphocyte count and derived Neutrophil to Lymphocyte ratio (dNLR)=neutrophil count/(leucocytes count – neutrophils count). Baseline analysis and after the second dose were used for the calculation of different ratios. Results The median age was 63 years (range 41–85), 55% were male. The baseline cut-off values for NLR were 2.61, for MLR 0.31, for PLR 110.14, for ALR 2.39 and for dNLR 1.71. The cut-off values after the 2° dose were, for NLR 2.3, for MLR 0.3, for PLR 131.61, ALR 4.16, and dNLR 1.48. Median progression-free survival (PFS) was 21.7 months (95% CI 10.7–32.8 months) and overall survival (OS) was 32.1 months (95% CI 19.6–44.7 months), PFS was shorter in patients with elevated NLR (P=0.001), ALR (0.03), and dNLR (P=0.001) in baseline analysis. DCR was 81% and ORR 18%. Conclusions In GEP or unknown origin NETs treated with PRRT, we have identified the predictive and prognostic impact of baseline systemic inflammatory factors (AU)

Descripción de un método de cuantificación diferente para la carga de amiloide (DPDload) y validación de SPECT/TC en amiloidosis cardíaca / Description of a different quantification method for amyloid burden (burdenDPD) and validation of SPECT/CT in cardiac amyloidosis

Introducción Los radiotrazadores con afinidad ósea como el [99mTc]Tc-DPD han demostrado una alta sensibilidad y especificidad en el diagnóstico no invasivo de la amiloidosis cardíaca (AC) por transtirretina (ATTR-AC). Este estudio tiene como objetivo validar el uso de la SPECT/TC y evaluar la utilidad de la cuantificación de la captación (cargaDPD) en el tejido miocárdico como información potencial sobre la carga amiloide. Métodos Se trata de un análisis retrospectivo de 46 pacientes con sospecha de AC, en el que 23 casos con ATTR-AC fueron sometidos a dos métodos de cuantificación para estimar la carga amiloide (cargaDPD) a través de imágenes planares y de una SPECT/TC. Resultados La SPECT/TC aportó un valor añadido significativo en el diagnóstico del paciente con AC (p<0,05). La estimación de la carga amiloide comprobó que la pared del VI más afectada es el tabique interventricular en la mayoría de los casos, y la existencia de una relación significativa entre la captación de Perugini y la carga de DPD. Conclusiones Validamos la necesidad de la SPECT/TC como complemento de la imagen planar en el diagnóstico de la AC-TTR. Por su parte, el cálculo de la carga amiloide continúa siendo un área de investigación compleja y requiere de más estudios, con un mayor número de pacientes, que permitan validar un método estandarizado de cuantificación de la carga de amiloide, tanto para el diagnóstico como para el seguimiento del tratamiento (AU)

Background Bone tracers such as [99mTc]Tc-DPD have shown high sensitivity and specificity in the non-invasive diagnosis of transthyretin cardiac amyloidosis (ATTR-AC). This study aims to validate SPECT/CT and assess the usefulness of uptake quantification (burdenDPD) in the myocardial tissue as potential information on the amyloid burden. Methods In a retrospective analysis of 46 patients with suspected CA, 23 cases with ATTR-AC had two quantification methods conducted to estimate amyloid burden (burdenDPD) through planar scintigraphic scans and a SPECT/CT. Results SPECT/CT significantly provided an added value in the patient's diagnosis with CA (P<.05). The estimation of the amyloid burden substantiated that the most affected wall of the LV is the interventricular septum in most cases and the existence of a significant relationship between the Perugini score uptake and the burdenDPD. Conclusions We validate the need for SPECT/CT to complement planar imaging in diagnosing ATTR-AC. For its part, quantifying the amyloid load continues to be a complex area of research. It requires further studies with a larger number of patients to validate a standardized method of amyloid load quantification, both for diagnosis and treatment monitoring (AU)

Role of systemic inflammatory factors in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with peptide receptor radionuclide therapy (PRRT): From biology to theragnosis.

AIM: Systemic inflammatory factors have been validated as indicators of ongoing systemic inflammation that could be predictive markers of poor prognosis for oncological outcomes. However, the prognostic impact of systemic inflammation markers is unknown in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with peptide receptor radionuclide therapy (PRRT). METHODS: We conducted an observational, retrospective, multicentric study of 40 patients with GEP or unknown origin NETs treated with PRRT between 2016 and 2020. The systemic inflammatory markers were calculated as follows: neutrophil to lymphocyte ratio (NLR)=neutrophil count/lymphocyte count, monocyte to lymphocyte ratio (MLR)=monocyte count/lymphocyte count, platelet to lymphocyte ratio (PLR)=platelet count/lymphocyte count, albumin to lymphocyte ratio (ALR)=albumin levels/lymphocyte count and derived Neutrophil to Lymphocyte ratio (dNLR)=neutrophil count/(leucocytes count - neutrophils count). Baseline analysis and after the second dose were used for the calculation of different ratios. RESULTS: The median age was 63 years (range 41-85), 55% were male. The baseline cut-off values for NLR were 2.61, for MLR 0.31, for PLR 110.14, for ALR 2.39 and for dNLR 1.71. The cut-off values after the 2° dose were, for NLR 2.3, for MLR 0.3, for PLR 131.61, ALR 4.16, and dNLR 1.48. Median progression-free survival (PFS) was 21.7 months (95% CI 10.7-32.8 months) and overall survival (OS) was 32.1 months (95% CI 19.6-44.7 months), PFS was shorter in patients with elevated NLR (p=0.001), ALR (0.03), and dNLR (p=0.001) in baseline analysis. DCR was 81% and ORR 18%. CONCLUSIONS: In GEP or unknown origin NETs treated with PRRT, we have identified the predictive and prognostic impact of baseline systemic inflammatory factors.

Disseminated Sporotrichosis in a Liver Transplant Patient: A Case Report.

Sporotrichosis is an infection caused by the fungus of the Sporothrix schenckii complex and can be particularly harmful in immunocompromised patients. We report the case of a 26-year-old male patient with a previous history of pulmonary infection who underwent a liver transplant for Budd-Chiari syndrome. After the procedure, he presented with persistent fever and leukocytosis. On the 13th post-operative day, he was diagnosed with thrombosis of the hepatic artery and underwent a second liver transplant 15 days after the first procedure. After the retransplant, he presented daily episodes of fever, even after the use of several antimicrobial, antiviral, and antifungal agents. A number of negative cultures from different sites were obtained. After an acute episode of mental confusion, the growth of S schenckii was observed in cultures from cerebrospinal fluid and ascites obtained from a diagnostic paracentesis. Treatment with amphotericin B was started but the patient died on the fourth day of antifungal treatment, from a massive gastrointestinal hemorrhage. We found no previous report in the literature of spontaneous dissemination of S schenckii to the abdominal cavity causing peritonitis.

Emergence of clonal complex 5 (CC5) methicillin-resistant Staphylococcus aureus (MRSA) isolates susceptible to trimethoprim-sulfamethoxazole in a Brazilian hospital

In this study, genotyping techniques including staphylococcal chromosomal cassette mec (SCCmec) typing, pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST) and restriction-modification tests were used to compare the molecular characteristics of methicillin-resistant Staphylococcus aureus (MRSA) isolates recovered at two times within a 10-year interval (1998 and 2008) from a tertiary Brazilian hospital. In addition, the antimicrobial susceptibility profiles were analyzed. All 48 MRSA isolates from 1998 and 85.7% from 2008 (48/56 isolates) displayed multidrug-resistance phenotypes and SCCmec III. All but one of the 13 representative SCCmec III isolates belonged to CC8 and had PFGE patterns similar to that of the BMB9393 strain (Brazilian epidemic clone of MRSA; BEC). In 2008, we found an increased susceptibility to rifampicin and chloramphenicol among the SCCmec III isolates. In addition, we detected the entrance of diverse international MRSA lineages susceptible to trimethoprim-sulfamethoxazole (SXT), almost all belonging to CC5. These non-SCCmec III isolates were related to the USA 300 (ST8-SCCmec IV; PFGE-type B), USA 800 (ST5-SCCmec IV; subtype D1), USA 100 (ST5-SCCmec II; subtype D2), and EMRSA-3/Cordobes (ST5-SCCmec I, type C) clones. To the best of our knowledge, this is the first report of the emergence of isolates genetically related to the EMRSA-3/Cordobes clone in southeast Brazil. In this regard, these isolates were the most common non-SCCmec III MRSA in our institution, accounting for 8.9% of all isolates recovered in 2008. Thus, despite the supremacy of BEC isolates in our country, significant changes may occur in local MRSA epidemiology, with possible consequences for the rationality of MRSA empiric therapy.

Emergence of clonal complex 5 (CC5) methicillin-resistant Staphylococcus aureus (MRSA) isolates susceptible to trimethoprim-sulfamethoxazole in a Brazilian hospital.

In this study, genotyping techniques including staphylococcal chromosomal cassette mec (SCCmec) typing, pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST) and restriction-modification tests were used to compare the molecular characteristics of methicillin-resistant Staphylococcus aureus (MRSA) isolates recovered at two times within a 10-year interval (1998 and 2008) from a tertiary Brazilian hospital. In addition, the antimicrobial susceptibility profiles were analyzed. All 48 MRSA isolates from 1998 and 85.7% from 2008 (48/56 isolates) displayed multidrug-resistance phenotypes and SCCmec III. All but one of the 13 representative SCCmec III isolates belonged to CC8 and had PFGE patterns similar to that of the BMB9393 strain (Brazilian epidemic clone of MRSA; BEC). In 2008, we found an increased susceptibility to rifampicin and chloramphenicol among the SCCmec III isolates. In addition, we detected the entrance of diverse international MRSA lineages susceptible to trimethoprim-sulfamethoxazole (SXT), almost all belonging to CC5. These non-SCCmec III isolates were related to the USA 300 (ST8-SCCmec IV; PFGE-type B), USA 800 (ST5-SCCmec IV; subtype D1), USA 100 (ST5-SCCmec II; subtype D2), and EMRSA-3/Cordobes (ST5-SCCmec I, type C) clones. To the best of our knowledge, this is the first report of the emergence of isolates genetically related to the EMRSA-3/Cordobes clone in southeast Brazil. In this regard, these isolates were the most common non-SCCmec III MRSA in our institution, accounting for 8.9% of all isolates recovered in 2008. Thus, despite the supremacy of BEC isolates in our country, significant changes may occur in local MRSA epidemiology, with possible consequences for the rationality of MRSA empiric therapy.

Uncaria tomentosa for Reducing Side Effects Caused by Chemotherapy in CRC Patients: Clinical Trial.

To evaluate the effectiveness of Uncaria tomentosa in minimizing the side effects of chemotherapy and improving the antioxidant status of colorectal cancer (CRC) patients, a randomized clinical trial was conducted. Patients (43) undergoing adjuvant/palliative chemotherapy with 5-Fluorouracil/leucovorin + oxaliplatin (FOLFOX4) were split into two groups: the UT group received chemotherapy plus 300 mg of Uncaria tomentosa daily and the C group received only FOLFOX4 and served as a control. Blood samples were collected before each of the 6 cycles of chemotherapy, and hemograms, oxidative stress, enzymes antioxidants, immunologic parameters, and adverse events were analyzed. The use of 300 mg of Uncaria tomentosa daily during 6 cycles of FOLFOX4 did not change the analyzed parameters, and no toxic effects were observed.

Postobturation pain and associated factors in adolescent patients undergoing one- and two-visit root canal treatment.

OBJECTIVES: This prospective study evaluated the frequency and intensity of postobturation pain and associated factors in adolescents undergoing one- and two-visit root canal treatment. METHODS: 121 patients aged 11-18 years presenting with molars with pulp necrosis were assigned randomly into two treatment groups: one- and two-visit (including interappointment dressing with calcium hydroxide paste). The canals of all teeth were prepared using a preflaring (2/3 middle-cervical) and step-back (1/3 apical) preparation techniques and filled with laterally compacted gutta-percha and sealer. Postobturation pain was recorded on a visual analogue scale (VAS) of 0-5. Data were statistically analyzed using multivariate logistic regression. RESULTS: The frequencies of postobturation pain were 10.5% (6/57) in the one-visit group and 23.0% (14/61) in the two-visit group. There were no statistically significant differences between the groups (p=0.07). The intensity of the pain was similar in both groups, particularly flare-ups, with a prevalence of 1.75% in the one-visit group and 1.65% in the two-visit group. Postobturation pain was significantly associated with the presence of preoperative pain (p=0.04; OR=3.54; CI 95%=1.02-12.30) and a positive culture at the time of obturation (p=0.00; OR=9.43; CI 95%=2.93-30.35). CONCLUSIONS: Postobturation pain was more present in the two-visit group, but was not statistically significant. The intensity of postobturation pain was similar. Effective microbiological control and the presence of preoperative pain may influence the postobturation pain in adolescents.

Características seminais, corpóreas e anatômicas do aparelho reprodutor de reprodutores da raça canchim aos 14 e 48 meses de idade. / Anatomical, corporal and seminal characteristics of the reproductive system of canchim breed reproductors at ages from 14 to 48 months / Características seminales, corpóreas y anatómicas del aparato reproductor de reproductores de la raza canchim a los 14 y 48 meses de edad

Foram utilizados 20 touros da raça Canchim em inatividade sexual, divididos em grupo 1 (G1), constituído de 10 animais com 14 meses de idade e grupo 2 (G2), com 10 animais de 48 meses de idade. A proposta desse estudo foi investigar as características dos ejaculados e das mensurações anatômicas do trato reprodutivo da raça Canchim. Os parâmetros obtidos foram: peso médio de 445,5 e 706,02 kg; circunferência escrotal de 31,80 e 36,25 cm e índice de massa corpórea de 270,33 e 346,73 kg/m2 para o G1 e G2, respectivamente, com diferenças significativas (p < 0,05) entre eles. Realizaram-se quatro colheitas de sêmen por touro por meio de eletroejaculação, com intervalos de 14 dias, verificando-se diferença significativa (p < 0,05) para os defeitos espermáticos totais, entre a primeira (5,48) e a terceira colheitas (1,08), no G2. Os resultados sugerem que o desenvolvimento do aparelho reprodutivo e a espermatogênese estão presentes aos 14 meses de idade.

Twenty bulls of the Canchin breed in sexual inactivity were divided in group 1(G1) with ten animals at the age of 14 months old and group 2 (G2) with ten animals at the age of 48 months old. The purpose of this study was to investigate the characteristics of the ejaculators and anatomic measurements of reproductive tract in Canchim breed. The parameters obtained were the average weight from 445.5 to 706.02 kg, scrotal circumference from 31.8 to 36.25 cm and Corporal Mass Index from 270.33 to 346.73 kg/m² for G1 and G2 respectively with a significant difference (p<0.05). Four semen collections per bull were made with electro ejaculation with intervals of 14 days, and it showed significant difference (p<0.05) for the total spermatic flaws, between the first (5.48) and the third collect (1.08) in G2. These results suggest that the development of the reproductive tract and the spermatogenesis are present at the age of 14 months old.

Fueron utilizados 20 toros de la raza Canchim en inactividad sexual, divididos en grupos:Grupo 1 (G1) con 10 animales, con edades de 14 meses y el grupo 2 (G2) con 10 animales, con edades de 48 meses, teniendo como objetivo verificar la adaptación al clima tropical, por medio de las características de los eyaculados y medidas anatómicas del aparato reproductivo. Los parámetros obtenidos fueron peso medio de 445,5 y 706,02 kg; circunferencia escrotal de 31,80 y 36,25 cm e índice de masa corpórea de 270,33 y 346,73 kg/m² para el G1 y G2, respectivamente, con diferencias significativas (p<0,05). Fueron realizadas cuatro colectas de semen por toro, con intervalo de 14 días, por medio de electroeyaculación verificando diferencias significativas (p<0,05) para los defectos espermáticos totales entre la primera (5,48) y la tercera colecta (1,08) en el G2. Los resultados sugieren que el desarrollo del aparato reproductor y la espermatogénesis están presentes a los 14 meses de edad.

Secreção de interferon-tau em embriões bovinos produzidos in vitro frescos e congelados / Interferon tau secretion in cattle embryos in vitro fertilized before and after cryopreservation

Avaliou-se a interferência da criopreservação sobre a secreção de interferon-tau (IFN-t) por embriões bovinos produzidos in vitro. Usaram-se dois grupos de tratamentos: I) constituído por embriões não criopreservados (fresco) e II) embriões criopreservados. Os embriões, após atingirem a fase de blastocisto (fresco ou imediatamente após o descongelamento dos criopreservados), continuaram a ser cultivados individualmente por mais sete dias. Do meio de cultivo em que se mantiveram os blastocistos retiraram-se alíquotas com três e sete dias do início do cultivo, para a avaliação da secreção de IFN-t pelos embriões cultivados. Os embriões congelados secretaram menos IFN-t do que aqueles não criopreservados(P<0,05), e com sete dias houve maior secreção do interferon do que com três dias (P<0,05). A criopreservação prejudicou a produção de IFN-t pelo trofoblasto e pode comprometer o reconhecimento materno da gestação e o desenvolvimento do embrião pós-descongelamento.

Secreção de interferon-tau em embriões bovinos produzidos in vitro frescos e congelados / Interferon tau secretion in cattle embryos in vitro fertilized before and after cryopreservation

Avaliou-se a interferência da criopreservação sobre a secreção de interferon-tau (IFN-t) por embriões bovinos produzidos in vitro. Usaram-se dois grupos de tratamentos: I) constituído por embriões não criopreservados (fresco) e II) embriões criopreservados. Os embriões, após atingirem a fase de blastocisto (fresco ou imediatamente após o descongelamento dos criopreservados), continuaram a ser cultivados individualmente por mais sete dias. Do meio de cultivo em que se mantiveram os blastocistos retiraram-se alíquotas com três e sete dias do início do cultivo, para a avaliação da secreção de IFN-t pelos embriões cultivados. Os embriões congelados secretaram menos IFN-t do que aqueles não criopreservados (P<0,05), e com sete dias houve maior secreção do interferon do que com três dias (P<0,05). A criopreservação prejudicou a produção de IFN-t pelo trofoblasto e pode comprometer o reconhecimento materno da gestação e o desenvolvimento do embrião pós-descongelamento.

The effect of cryopreservation in IFN-tau, from bovine embryos produced in vitro was evaluated. Two treated groups (G1= fresh bovine embryos, n=59 and G2= freezed embryos, n=84) were used to study the effect of cryopreservation on IFN-tau secretion. After reaching the blastocyst phase, the embryos were kept on individual culture for additional period of 7 days. On days 3 and 7 after the beginning of embryos cultivation, samples of the media culture were taken for IFN-tau secretion titration. Oocysts taken from follicles ranging from 3 to 5mm in diameter were obtained from ovaries of females at slaughterhouse. The embryos were frozen, after being dehydrated with ethylene glycol (1.8m), conditioned on 0.5ml palletes and frozen. Frozen embryos secreted lower IFN-tau than fresh embryos (P<0.05). At day 7 it was registered higher IFN-tau secretion from trophoblast than at day 3 (P<0.05). The increasing of IFN-tau secretion was observed when the blastocyst began to longed and it was directly related to the embryos development. The synthesis of IFN-tau is related to the capability of development of the blastocyst. Cryopreservation is a method that affects the maternal recognition of pregnancy and the post-freezing embryo development.

A continuous fluorescent assay for the determination of plasma and tissue angiotensin I-converting enzyme activity.

A continuous assay using internally quenched fluorescent peptides with the general sequence Abz-peptidyl-(Dnp)P-OH (Abz = ortho-aminobenzoic acid; Dnp = 2,4-dinitrophenyl) was optimized for the measurement of angiotensin I-converting enzyme (ACE) in human plasma and rat tissues. Abz-FRK(Dnp)P-OH, which was cleaved at the Arg-Lys bond by ACE, was used for the enzyme evaluation in human plasma. Enzymatic activity was monitored by continuous recording of the fluorescence (lambda ex = 320 nm and lambda em = 420 nm) at 37 degrees C, in 0.1 M Tris-HCl buffer, pH 7.0, with 50 mM NaCl and 10 microM ZnCl2. The assays can be performed directly in the cuvette of the fluorimeter and the hydrolysis followed for 5 to 10 min. ACE measurements in the plasma of 80 healthy patients with Hip-His-Leu and with Abz-FRK(Dnp)P-OH correlated closely (r = 0.90, P < 0.001). The specificity of the assay was demonstrated by the complete inhibition of hydrolysis by 0.5 microM lisinopril or captopril. Abz-FRK(Dnp)P-OH cleavage by ACE was monitored in rat lung, kidney, heart, and liver homogenates in the presence of a cocktail of inhibitors containing trans-epoxy-succinyl-L-leucylamido-(4-guanido)-butene, pepstatin, phenyl-methylsulfonyl fluoride, N-tosyl-L-phenylalanyl-chloromethyl ketone, and N-tosyl-lysyl-chloromethyl ketone to prevent undesirable hydrolysis. ACE activity in lung, heart and kidney homogenates, but not in liver homogenates, was completely abolished by 0.5 microM lisinopril or captopril. The advantages of the method are the procedural simplicity and the high sensitivity providing a rapid assay for ACE determinations.

A continuous fluorescent assay for the determination of plasma and tissue angiotensin I-converting enzyme activity

A continuous assay using internally quenched fluorescent peptides with the general sequence Abz-peptidyl-(Dnp)P-OH (Abz = ortho-aminobenzoic acid; Dnp = 2,4-dinitrophenyl) was optimized for the measurement of angiotensin I-converting enzyme (ACE) in human plasma and rat tissues. Abz-FRK(Dnp)P-OH, which was cleaved at the Arg-Lys bond by ACE, was used for the enzyme evaluation in human plasma. Enzymatic activity was monitored by continuous recording of the fluorescence (lambdaex = 320 nm and lambdaem = 420 nm) at 37°C, in 0.1 M Tris-HCl buffer, pH 7.0, with 50 mM NaCl and 10 æM ZnCl2. The assays can be performed directly in the cuvette of the fluorimeter and the hydrolysis followed for 5 to 10 min. ACE measurements in the plasma of 80 healthy patients with Hip-His-Leu and with Abz-FRK(Dnp)P-OH correlated closely (r = 0.90, P < 0.001). The specificity of the assay was demonstrated by the complete inhibition of hydrolysis by 0.5 æM lisinopril or captopril. Abz-FRK(Dnp)P-OH cleavage by ACE was monitored in rat lung, kidney, heart, and liver homogenates in the presence of a cocktail of inhibitors containing trans-epoxy-succinyl-L-leucylamido-(4-guanido)-butene, pepstatin, phenyl-methylsulfonyl fluoride, N-tosyl-L-phenylalanyl-chloromethyl ketone, and N-tosyl-lysyl-chloromethyl ketone to prevent undesirable hydrolysis. ACE activity in lung, heart and kidney homogenates, but not in liver homogenates, was completely abolished by 0.5 æM lisinopril or captopril. The advantages of the method are the procedural simplicity and the high sensitivity providing a rapid assay for ACE determinations.

IgA secretora total e específica no colostro e leite de mães da cidade do Natal-Rio Grande do Norte, Brasil / Total and specific IgA in colostrum and milk of mothers of Natal-Rio Grande do Norte, Brasil

PURPOSE: To determine the concentration of total secretory IgA and evaluate the repertoire of IgA antibodies to enteropathogenic Escherichia coli and Shigella flexneri antigens in colostrums and milk from mothers in Natal, RN. METHODS: The sample was constituted by 22 healthy clinically women whose babies were born at public hospital in Natal, RN. To determine total secretory IgA a radial immunedifusion tecnique (Mancini et al, 1965), was employed and to detect specific antibodies, immuneenzimatic assays, ELISA was used. RESULTS: The median values of total secretory IgA concentration presented individual variations with high levels in colostrums samples, decreasing during lactation, it was observed a p < 0.001 among the samples from the first day of lactation, to the thirtieth for total IgA concentration. All the donators present in colostrum and milk specific antibodies to Escherichia coli enteropathogenic (EPEC) and Shigella flexneri with titles higer in colostrum. There was parallel and directional pattern between total IgA and IgA anti-EPEC and Shegella flexneri, during period. CONCLUSION: The concentrations of total SIgA and specific antibodies to enteropathogenic Escherichia coli and Shigella flexneri in colostrums and milk in our study do not differ from others accomplished among populations with the same social and econimic features, stressing the importance of human milk as a protector agent against pathogens.

Desenvolvimento pós-fecundaçäo de oócitos bovinos pré-maturados em fluido folicular / Post-fertilization development of bovine oocytes pre-matured in follicular fluid

Estudou-se o efeito da pré-maturaçäo em fluido folicular bovino (FFb) sobre o potencial de desenvolvimento de ovócitos bovinos imaturos. Complexo cumulus- ovócitos (CCO) e FFb foram obtidos de ovários coletados em matadouro. O FFb foi inativado e os CCOs imaturos distribuídos em quatro tratamentos: (T1) 70 por cento de FFb em Talp Hepes, (T2) 100 por cento de FFb, (T3) 100 por cento de Talp Hepes, e (T4) controle. Em T1, T2 e T3 os CCOs foram pré - maturados por cinco horas a 37ºC em ar e posteriormente maturados in vitro. Em T4 a maturaçäo ocorreu logo após a aspiraçäo. Depois de fecundados in vitro, os ovócitos foram co-cultivados com células do cumulus por 10 dias. Avaliaram-se as taxas de clivagem, de produçäo de blastocistos no sétimo e oitavo dias pós- fecundaçäo (PF), de produçäo total e de blastocistos eclodidos no oitavo e nono dias PF. Calcularam-se as taxas de blastocistos no sétimo e oitavo dia e de blastocistos eclodidos em funçäo do total de blastocistos produzidos. As taxas de clivagem, de produçäo total e de blastocistos eclodidos näo diferiram entre os tratamentos (P>0,05), entretanto a produçäo de blastocistos no sétimo dia foi menor nos tratamentos com FFb e Talp Hepes (P<0,05). Concluiu-se que FFb e Talp Hepes na pré-maturaçäo por cinco horas atrasam o desenvolvimento embrionário sem comprometer a taxa de produçäo total de embriöes ou sua viabilidade.

Taurina no desenvolvimento de embriões bovinos fecundados in vitro

The effect of different taurine concentrations on bovine embryo development in medium supplemented with different serum sources was studied. In the first experiment, in vitro fertilized zygotes (n=440) were divided into treatments with 0, 3, 7 or 14 mM of taurine in culture medium supplemented with 10% of fetal calf serum (FCS) and 3g/l of bovine serum albumin (BSA). In the second experiment, zygotes (n=940) were divided into treatments with 0, 3 or 14 mM of taurine in cultured medium supplemented with 10% of FCS or 3g/l of BSA. In the third experiment, zygotes (n=191) were divided into treatments with 0 or 3 mM of taurine in culture medium without serum source, even so supplemented with 3g/l of polyvinyl alcohol. In the first and second experiments no differences (P>0.05) in cleavage rate, blastocyst production and cells number among the concentrations of taurine were observed. In the third experiment, taurine increased (P 0.05) cleavage rate (68.5% vs. 16.9%) and blastocysts production (8.3% vs. 0%). The culture of zygotes in medium supplemented with FCS produced more (P 0.01) blastocyst in the seventh (25.6% vs. 6.7%) and eighth (30.8% vs. 13.9%) day post-fertilization and total cells number/blastocysts (104.8± 2.63 vs. 84.7± 3.86) than in medium with BSA, despite lower (P 0.01) cleavage rate (58.1% vs. 71.3%). In conclusion, taurine only has a beneficial effect in the embryo development in culture medium in the absence of FCS and BSA. Fetal calf serum decreases cleavage rate, however, it improves the embryo development after the early cleavage.

O objetivo deste trabalho foi avaliar o efeito de diferentes concentrações de taurina no desenvolvimento de embriões bovinos fecundados in vitro em meio de cultivo com diferentes fontes de soro. No experimento 1, zigotos (n=440) fecundados in vitro foram distribuídos aleatoriamente nos tratamentos com 0, 3, 7 ou 14 mM de taurina em meio de cultivo acrescido de 10% de soro fetal bovino (SFB) e 3g/l de albumina sérica bovina (BSA). No experimento 2, os zigotos (n=940) foram divididos nos tratamentos com 0, 3 ou 14 mM de taurina em meio acrescido de 10% de SFB ou 3g/l de BSA. No experimento 3, os zigotos (n=191) foram divididos nos tratamentos com 0 ou 3 mM de taurina em meio de cultivo sem fonte de soro, porém adicionado de 3 g/l de álcool polivinil. Nos experimentos 1 e 2 não se observou diferença (P>0,05) na taxa de clivagem, na produção de blastocistos e no número de células entre as concentrações de taurina avaliadas. No experimento 3 encontraram-se maior (P 0,05) taxa de clivagem (68,5% vs. 16,9%) e produção de blastocistos (8,3% vs. 0%) na presença de taurina. O cultivo de zigotos em meio adicionado de SFB produziu maior (P 0,01) taxa de blastocistos no sétimo (25,6% vs. 6,7%) e oitavo (30,8% vs. 13,9%) dia pós-fecundação e número de células/blastocistos (104,8± 2,63 vs. 84,7± 3,86) do que no cultivo com BSA, apesar de menor (P 0,01) taxa de clivagem (58,1% vs. 71,3%). Conclui-se que o efeito benéfico da taurina no desenvolvimento embrionário somente é observado na ausência de SFB e BSA. O SFB produz menor taxa de clivagem mas melhora o desenvolvimento embrionário após as primeiras divisões celulares.

Taurina no desenvolvimento de embriöes bovinos fecundados in vitro / Taurine on the development of in vitro fertilized bovine embryos

O objetivo deste trabalho foi avaliar o efeito de diferentes concentraçöes de taurina no desenvolvimento de embriöes bovinos fecundados in vitro em meio de cultivo com diferentes fontes de soro. No experimento 1, zigotos (n=440) fecundados in vitro foram distribuídos aleatoriamente nos tratamentos com 0, 3, 7 ou 14 mM de taurina em meio de cultivo acrescido de 10 por cento de soro fetal bovino (SFB) e 3g/l de albumina sérica bovina (BSA). No experimento 2, os zigotos (n=940) foram divididos nos tratamentos com 0, 3 ou 14 mM de taurina em meio acrescido de 10 por cento de SFB ou 3g/l de BSA. No experimento 3, os zigotos (n=191) foram divididos nos tratamentos com 0 ou 3 mM de taurina em meio de cultivo sem fonte de soro, porém adicionado de 3 g/l de álcool polivinil. Nos experimentos 1 e 2 näo se observou diferença (P>0,05) na taxa de clivagem, na produçäo de blastocistos e no número de células entre as concentraçöes de taurina avaliadas. No experimento 3 encontraram-se maior (P<0,05) taxa de clivagem (68,5 por cento vs. 16,9 por cento) e produçäo de blastocistos (8,3 por cento vs. 0 por cento) na presença de taurina. O cultivo de zigotos em meio adicionado de SFB produziu maior (P<0,01) taxa de blastocistos no sétimo (25,6 por cento vs. 6,7 por cento) e oitavo (30,8 por cento vs. 13,9 por cento) dia pós-fecundaçäo e número de células/blastocistos (104,8± 2,63 vs. 84,7± 3,86) do que no cultivo com BSA, apesar de menor (P<0,01) taxa de clivagem (58,1 por cento vs. 71,3 por cento). Conclui-se que o efeito benéfico da taurina no desenvolvimento embrionário somente é observado na ausência de SFB e BSA. O SFB produz menor taxa de clivagem mas melhora o desenvolvimento embrionário após as primeiras divisöes celulares